Parmax Pharma Ltd — Insider Trading, 01-10-2025: Insider Trading / SAST

Parmax Pharma Limited has announced the closure of its trading window for Designated Persons with immediate effect. This closure is in anticipation of the financial results for the quarter and half-year ended September 30, 2025. The trading window will remain closed until 48 hours after these results are declared, preventing insider trading. The company will announce the date of the board meeting to consider these financial results in due course.